SNHG3 and thyroid cancer: To investigate the effect of SNHG3, CRISPR/Cas9 mediated gene disruption was employed in thyroid cancer cell lines (SNHG3-KO) and resulted in strong reduction of SNHG3 levels and induced pro-tumorigenic effects, such cell proliferation, migration and invasion [78].